Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Recce Ltd (RCE AU)
Watchlist
9
Analysis
Health Care
•
Australia
Recce Limited produces pharmaceutical products. The Company offers antibiotics to kill bacteria. Recce markets its products in Australia.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Recce Ltd
•
12 Jul 2024 01:10
•
Issuer-paid
Recce Pharmaceuticals - Taking a closer look at diabetic foot infections
We highlight the opportunity of topical RECCE® 327 (R327) to address diabetic foot infections (DFIs), which is the leading cause of limb morbidity...
Edison Investment Research
Follow
192 Views
Share
bullish
•
Recce Ltd
•
08 May 2024 07:10
•
Issuer-paid
Recce Pharmaceuticals - Advances on several fronts
Recce Pharmaceuticals has reported several encouraging developments in recent weeks for its lead development compound RECCE® 327 (R327). The...
Edison Investment Research
Follow
178 Views
Share
bullish
•
Recce Ltd
•
27 Mar 2024 13:10
•
Issuer-paid
Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway
Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax...
Edison Investment Research
Follow
226 Views
Share
bullish
•
Recce Ltd
•
20 Feb 2024 19:10
•
Issuer-paid
Recce Pharmaceuticals - Supportive advancements on the pipeline
Recce Pharmaceuticals has announced several positive developments in recent weeks relating to its therapeutic programmes, particularly for lead...
Edison Investment Research
Follow
216 Views
Share
bullish
•
Recce Ltd
•
21 Dec 2023 01:10
•
Issuer-paid
Recce Pharmaceuticals - Landmark commitment helps fund R&D costs
Recce recently reported that the Australian government has committed to providing up to A$55m in future cash rebates to reimburse upcoming R&D...
Edison Investment Research
Follow
301 Views
Share
1
2
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x